Ocular Laboratory for Analysis of Biomarkers (OCULAB)

10 April 2025: The purpose of this amendment is to incorporate updates to Appendix C to ensure compliance with the Executive Orders, see file titled "APPENDIX C FULL PROPOSAL FORMAT AND INSTRUCTIONS ver 2 4.10.2025" 31 March 2025: The purpose of this amendment is to provide an updated Cost Proposal Spreadsheet for Other Transaction, see document titled "ARPA-H COST PROPOSAL SPREADSHEET (Other Transaction)

03.31.2025" 26 March 2025: The purpose of this amendment is to provide an updated Cost Proposal Spreadsheet for Other Transactions 25 March 2025: The purpose of this amendment is to incorporate changes to the ISO, see document titled "ARPA-H-SOL-25-115 OCULAB ISO Amend 03 3.25.25". The following sections are updated: Sections, 1.2.1.1, 1.2.1.2, Figure 3, 1.3.1 Table 1, 1.3.2 Table 2, 1.4.3, and 4.2.3.4; and incorporates updates to ensure compliance with the Executive Orders.

17 January 2025: The purpose of this amendment is to incorporate changes to the ISO, see document titled "ARPA-H-SOL-25-115 OCULAB ISO Amend 02 1.17.25" 10 January 2025: The purpose of this amendment is to incorporate changes to the ISO, see document titled "ARPA-H-SOL-25-115 OCULAB ISO Amend 01 1.10.25".

20 December 2024: The purpose of this amendment is to provide the Final OCULAB ISO along with all applicable attachments.

18 October 2024: The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of the OCUlar Laboratory for Analysis of Biomarkers (OCULAB) Program. ARPA-H anticipates multiple awards and award types will result from this announcement. Interested parties are invited to review the attached draft OCULAB Innovative Solutions Opening (ISO) ARPA-H-SOL-25-115.